A5070809137- Reproductive Health and Contraception
- Sexual function and dysfunction studies
- Maternal Mental Health During Pregnancy and Postpartum
- Menstrual Health and Disorders
- Menopause: Health Impacts and Treatments
- Reproductive Health and Technologies
- Health and Medical Studies
- Global Maternal and Child Health
- Endometriosis Research and Treatment
- Hormonal and reproductive studies
- Maternal and Perinatal Health Interventions
- Medical and Health Sciences Research
- Pregnancy and Medication Impact
- Ovarian function and disorders
- Sexuality, Behavior, and Technology
- Uterine Myomas and Treatments
- Sex and Gender in Healthcare
- Cancer survivorship and care
- Adolescent Sexual and Reproductive Health
- Sexual Differentiation and Disorders
- Estrogen and related hormone effects
- LGBTQ Health, Identity, and Policy
- Family Support in Illness
- Pelvic floor disorders treatments
- Genital Health and Disease
Women's Hospital
2008-2024
University Hospital of Basel
2015-2024
University of Basel
2015-2024
Universitäts Frauenklinik
2007-2022
European Society of Human Reproduction and Embryology
2010-2020
Freiwillige Akademische Gesellschaft
2019
Swisse (Australia)
2018
Praxis
2003-2018
Swissmedic
2018
European Society of Clinical Microbiology and Infectious Diseases
2017
Affective disorder during pregnancy is a common condition requiring careful judgment to treat the depression while minimizing risk fetus. Following up on promising pilot trials, we studied efficacy of light therapy.Twenty-seven pregnant women with nonseasonal major depressive according DSM-IV (outpatients, university polyclinic) were randomly assigned 7,000 lux fluorescent bright white or 70 dim red (placebo) administered at home in morning upon awakening for 1 h/d 5-week double-blind trial...
Abstract This Position Statement has been endorsed by the International Menopause Society, The Endocrine European and Andropause Society for Sexual Medicine, Study of Women's Health, North American Federacion Latinoamericana de Sociedades Climaterio y Menopausia, Royal College Obstetricians Gynecologists, Endocrinology, Australia, Australian New Zealand Gynecologists.*
Abstract Background With the aim to simplify cancer management, research lately dedicated itself more and discover develop non-invasive biomarkers. In this connection, circulating cell-free DNA (ccf DNA) seems be a promising candidate. Altered levels of ccf nuclear (nDNA) mitochondrial (mtDNA) have been found in several types might diagnostic value. Methods Using multiplex real-time PCR we investigated nDNA mtDNA plasma samples from patients with malignant benign breast tumors, healthy...
Several data indicate that migraine, especially migraine with aura, is associated an increased risk of ischemic stroke and other vascular events. Of concern whether the in migraineurs magnified by use hormonal contraceptives. As prevalence high women reproductive age, it common to face issue contraceptive clinical practice. In this document, we systematically reviewed about association between use. Thereafter a consensus procedure among international experts was done develop statements...
Background Aberrant DNA methylation patterns might be used as a biomarker for diagnosis and management of cancer patients. Methods Findings To achieve gene panel developing breast blood-based test we quantitatively assessed the proportion 248 CpG sites per sample (total 31,248 in all analyzed samples) on 10 candidate genes (APC, BIN1, BMP6, BRCA1, CST6, ESR-b, GSTP1, P16, P21 TIMP3). The number 126 samples consisting two different cohorts was (first cohort: plasma from patients normal...
This Position Statement has been endorsed by the International Menopause Society, The Endocrine European and Andropause Society for Sexual Medicine...
Aims Breakthrough bleeding or even unwanted pregnancies have been reported in women during concomitant therapy with oral contraceptives and St John's wort extract. The aim of the present study was to investigate effects extract on contraceptive respect ovarian activity, breakthrough episodes pharmacokinetics ethinyloestradiol 3‐ketodesogestrel. Methods Eighteen healthy females were treated a low‐dose (0.02 mg ethinyloestradiol, 0.150 desogestrel) alone (control cycle) combined 300 given...
Objective: Although sex-disaggregated data for COVID-19 show equal numbers of cases between men and women, there seem to be sex differences in mortality rate vulnerability the disease: more than women are dying.